JPRN-UMIN000047431已完成未知
Immune checkpoint inhibitors for ocular melanoma - Immune checkpoint inhibitors for ocular melanoma
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Others,meta-analysis etc
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with ocular melanoma who were treated with ICI as adjuvant/neoadjuvant therapy
研究者
相似试验
已完成
不适用
Pruritus and Melanoma and Cutaneous Carcinomas Treated With ImmunotherapyPruritusNCT04365244University Hospital, Brest181
进行中（未招募）
1 期
Treatment of skin cancer using a different approach than surgery using an electroporation device that makes the tumour absorb more drug while leaving the healthy tissue alone combined with an immune modulator that enhances the anti-tumour immune response.Advanced Melanoma CancerEUCTR2014-004420-22-IEniversity College Cork10
招募中
2 期
Melanoma Metastasized to the Brain and SteroidsMalignant MelanomaNCT03563729Inge Marie Svane80
Unknown
不适用
Melanoma Inhibitory Activity (MIA): A Serological Marker for Metastatic Uveal MelanomaRadiotherapyMetastatic DiseaseMelanomaNCT00406900Ludwig-Maximilians - University of Munich560
尚未招募
不适用
TriaL to investigAte imMune checkpoint inhibitor related siccA syndromespeekselproductiedry eyes and/or dry mouth10030064NL-OMON56760Erasmus MC, Universitair Medisch Centrum Rotterdam100